DH · XBRL financial data
Definitive Healthcare financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (DH's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | 166 | 223 | 251 | 252 | 242 |
| Cost of revenue | — | 43 | 47 | 55 | 58 |
| Gross profit | 125 | 180 | 204 | 197 | 183 |
| Research and development | 19 | 35 | 42 | 37 | 35 |
| General and administrative | 31 | 52 | 59 | 49 | 52 |
| Total operating expenses | 150 | 224 | 534 | 908 | 408 |
| Operating income (loss) | (25) | (44) | (330) | (711) | (224) |
| Interest expense | 26 | 8 | 15 | 15 | 11 |
| Other income (expense) | (36) | 2 | 22 | 77 | 15 |
| Income tax expense (benefit) | 1 | (18) | (19) | (42) | (10) |
| Net income (loss) | (18) | (7) | (202) | (413) | (139) |
| Earnings per share, basic USD per share | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| Earnings per share, diluted USD per share | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| Weighted average shares, basic millions of shares | 92 | 101 | 113 | 117 | 107 |
| Weighted average shares, diluted millions of shares | 92 | 101 | 113 | 117 | 107 |
Balance sheet
CSVFiscal years (DH's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 387 | 147 | 131 | 105 | 164 |
| Short-term investments | 0 | 185 | 177 | 185 | 17 |
| Accounts receivable | 43 | 59 | 59 | 53 | 52 |
| Prepaid and other current assets | 7 | 13 | 13 | 13 | 12 |
| Total current assets | 444 | 414 | 394 | 370 | 258 |
| Property and equipment, net | 5 | 4 | 4 | 4 | 13 |
| Right-of-use asset | 0 | 10 | 10 | 8 | 5 |
| Goodwill | 1,261 | 1,325 | 1,075 | 393 | 197 |
| Total assets | 2,116 | 2,123 | 1,826 | 1,089 | 735 |
| Accounts payable | 5 | 4 | 6 | 11 | 4 |
| Accrued liabilities | 23 | 27 | 52 | 41 | 45 |
| Current portion of long-term debt | 7 | 9 | 14 | 14 | 9 |
| Total current liabilities | 118 | 141 | 171 | 161 | 157 |
| Long-term debt | 264 | 256 | 243 | 229 | 156 |
| Lease liability, non-current | 0 | 10 | 9 | 8 | 5 |
| Total liabilities | 613 | 641 | 627 | 482 | 357 |
| Accumulated deficit | (18) | (25) | (227) | (641) | (780) |
| Total liabilities and equity | 2,116 | 2,123 | 1,826 | 1,089 | 735 |
| Common shares outstanding (cover page) millions of shares | 97 | 108 | 118 | 113 | 104 |
Cash flows
CSVFiscal years (DH's year ends in late December)
| In millions of dollars | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|
| Net income (loss) | (18) | (7) | (202) | (413) | (139) |
| Stock-based compensation | 10 | 36 | 49 | 38 | 29 |
| Depreciation and amortization | 2 | 2 | 2 | 2 | 3 |
| Net cash from operating activities | 25 | 36 | 41 | 58 | 54 |
| Purchases of property and equipment | 7 | 8 | 3 | 12 | 17 |
| Net cash from investing activities | (47) | (249) | (32) | (26) | 154 |
| Proceeds from issuing common stock | 835 | 0 | 0 | — | — |
| Share repurchases | — | 0 | 0 | 22 | 49 |
| Proceeds from long-term debt | 275 | 0 | 0 | — | — |
| Repayments of long-term debt | — | 7 | 9 | 14 | 253 |
| Net cash from financing activities | 384 | (27) | (26) | (57) | (151) |
| Net change in cash | 363 | (240) | — | — | — |
Compare with peers
SIC 7372 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 7372 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Definitive Healthcare | 171 | 55 | 11* | 106.7M | — | 10-QJun 30, 2026 |
| CS Disco | 13 | 45 | (3)* | 65.7M | 14.5 quarters | 10-QSep 30, 2026 |
| ReposiTrak | 27 | not reported | 2.4* | 18.2M | — | 10-KJun 30, 2026 |
| Telos | 51 | 48 | 8.8* | 74.7M | — | 10-QJun 30, 2026 |
| On24 | 37 | 35* | (1.1)* | 42.9M | 158.0 quarters | 10-KDec 31, 2025 |
| HawkEye 360 | 503 | 50 | 12* | 98.0M | — | 10-QJun 30, 2026 |
| Expensify | 66 | 34 | 8.4* | not reported | — | 10-QJun 30, 2026 |
| Tucows | 44 | not reported | 1.9 | 11.2M | — | 10-QJun 30, 2026 |
| Rackspace Technology | 111 | 670 | (32)* | 254.9M | 3.5 quarters | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
